Joseph Romanelli Returns to Merck as President of Human Health International Markets
Apr 21, 2022 10:11
CST Updated
10:11
MSD
Pharmaceutical R&D and Manufacturer
On April 20, Rob Davis, Global CEO of MSD, announced that former President of MSD China, Rogerio Vivaldi, who had left MSD nine months ago, will return to MSD in August this year to serve as the President of MSD's Human Health International Markets.
*Disclaimer: This article was written by an author who has settled in Sina Medicine News. The views expressed represent the personal opinions of the author and do not reflect the position of Sina Medicine News.